MedTrace Logo

To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.

NCT01984528 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-01-05

No results posted yet for this study

Summary

The objetive of this study is to determine the minimum amount of Alternaria alternata allergen extract producing in a positive skin reaction.

Conditions

  • Allergy to Alternaria Fungus

Interventions

BIOLOGICAL

four differente concentrations of Alternaria alternata allergen extract, positive control and negative control

This concentrations will be tested in every patient in duplicate on the volar surface of the forearm.

Sponsors & Collaborators

  • Laboratorios Leti, S.L.

    lead INDUSTRY

Principal Investigators

  • Lena Erbiti · Laboratorios Leti, S.L.U

  • Santiago Quirce, MD · Hospital Universitario La Paz

  • José Damian López, MD · HOSPITAL CLÍNICO UNIVERSITARIO VIRGEN DE LA

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01984528 on ClinicalTrials.gov